Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Agile Therapeutics Inc (AGRX)

Agile Therapeutics Inc (AGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 10,353
  • Shares Outstanding, K 6,856
  • Annual Sales, $ 19,590 K
  • Annual Income, $ -14,470 K
  • 60-Month Beta 1.58
  • Price/Sales 0.53
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AGRX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -4.24
  • Most Recent Earnings $-0.68 on 08/12/24
  • Next Earnings Date 08/14/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -9.00
  • Growth Rate Est. (year over year) +11,200.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4300 +5.59%
on 07/29/24
1.5200 -0.66%
on 08/22/24
+0.0600 (+4.14%)
since 07/26/24
3-Month
0.3100 +387.10%
on 06/20/24
1.5200 -0.66%
on 08/22/24
+1.1351 (+302.77%)
since 05/24/24
52-Week
0.2000 +655.00%
on 03/26/24
2.6300 -42.59%
on 09/01/23
-0.5500 (-26.70%)
since 08/25/23

Most Recent Stories

More News
Agile Therapeutics: Q1 Earnings Snapshot

Agile Therapeutics: Q1 Earnings Snapshot

AGRX : 1.5100 (unch)
Agile Therapeutics: Q4 Earnings Snapshot

Agile Therapeutics: Q4 Earnings Snapshot

AGRX : 1.5100 (unch)
Agile Therapeutics: Q3 Earnings Snapshot

Agile Therapeutics: Q3 Earnings Snapshot

AGRX : 1.5100 (unch)
Why Shares of Agile Therapeutics Jumped This Week

The women's healthcare company got an analyst upgrade.

AGRX : 1.5100 (unch)
Agile Therapeutics: Q2 Earnings Snapshot

Agile Therapeutics: Q2 Earnings Snapshot

AGRX : 1.5100 (unch)
Blue Bird, First Solar rise; Harrow Health, Telesis Bio fall

Stocks that traded heavily or had substantial price changes Friday: Blue Bird, First Solar rise; Harrow Health, Telesis Bio fall

NWSA : 26.45 (+0.42%)
AGRX : 1.5100 (unch)
FSLR : 241.81 (+0.76%)
SPB : 91.86 (+0.03%)
BLBD : 51.13 (+1.94%)
Agile Therapeutics: Q1 Earnings Snapshot

Agile Therapeutics: Q1 Earnings Snapshot

AGRX : 1.5100 (unch)
Agile Therapeutics: Q4 Earnings Snapshot

Agile Therapeutics: Q4 Earnings Snapshot

AGRX : 1.5100 (unch)
Corium Pharma Solutions Appoints Mark Sirgo as Chief Executive Officer

Corium Pharma Solutions, Inc. (“Corium Pharma Solutions” or “CPSI”), a leading, full-service contract development and manufacturing organization specializing in novel drug delivery technologies,...

PG : 173.92 (-1.11%)
AGRX : 1.5100 (unch)
NMTR : 0.0722 (-42.97%)
GNTA : 3.30 (unch)
Agile Therapeutics: Q3 Earnings Snapshot

Agile Therapeutics: Q3 Earnings Snapshot

AGRX : 1.5100 (unch)

Business Summary

Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. It is focused on the development and commercialization of new prescription contraceptive products. The Company's lead product candidate is Twirla (TM), also known as AG200-15, a once-weekly prescription contraceptive patch...

See More

Key Turning Points

3rd Resistance Point 1.5183
2nd Resistance Point 1.5167
1st Resistance Point 1.5133
Last Price 1.5100
1st Support Level 1.5083
2nd Support Level 1.5067
3rd Support Level 1.5033

See More

52-Week High 2.6300
Fibonacci 61.8% 1.7017
Last Price 1.5100
Fibonacci 50% 1.4150
Fibonacci 38.2% 1.1283
52-Week Low 0.2000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar